Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
Amyotrophic lateral sclerosis (ALS) is a multi-system disorder. Mild cognitive deficits are present in a subgroup of non-demented patients with ALS. Detailed neuropsychological assessments reveal deficits of word retrieval including impairments on tests of verbal fluency and confrontation naming. Th...
Main Authors: | Wicks, P, Turner, M, Abrahams, S, Hammers, A, Brooks, D, Leigh, P, Goldstein, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
by: Wicks, P, et al.
Published: (2005) -
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
by: Turner, M, et al.
Published: (2007) -
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
by: Turner, M, et al.
Published: (2007) -
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET
by: Turner, M, et al.
Published: (2005) -
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
by: Turner, M, et al.
Published: (2005)